Skip to main content
SpringerLink
Log in

Experience of the Eliava Institute in bacteriophage therapy

  • Insight
  • Published:
Virologica Sinica

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  • Alavidze Z, Kutateladze M. Bacteriophage therapy. 2001. New York: Academic Press, pp. 89–92.

    Google Scholar 

  • Kutateladze M, Adamia R. 2008. Medicine et Maladies Infectiouses, 38: 426–430.

    Article  CAS  Google Scholar 

  • Kutateladze M, Adamia R. 2010. Trends Biotechnol, 28: 591–595.

    Article  CAS  PubMed  Google Scholar 

  • Fitzgerald-Hughes D, Bolkvadze D, Balarjishvili N, et al. 2014. J Antimicrob Chemoth, 69:1148–1150.

    Article  CAS  Google Scholar 

  • Kutter E, Borysowski J, Miedzybrodzki R, et al. Norfolk: Caister Academic Press, pp. 257–288.

Download references

Author information

Authors and Affiliations

  1. George Eliava Institute of Bacteriophages, Microbiology and Virology, Tbilisi, 0160, Georgia

    Mzia Kutateladze

Authors
  1. Mzia Kutateladze
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Mzia Kutateladze.

Additional information

ORCID: 0000-0002-7566-7278

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kutateladze, M. Experience of the Eliava Institute in bacteriophage therapy. Virol. Sin. 30, 80–81 (2015). https://doi.org/10.1007/s12250-014-3557-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12250-014-3557-0

Keywords

Search

Navigation